Search

everythinglearnresearchcommunity

for

Search:↓

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

The research found specific genes and proteins that affect how fast chickens' feathers grow, which is not solely determined by traditional inheritance patterns.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

JAK inhibitors, PRP, and exosomes show promise for hair regrowth in Alopecia Areata.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Tofacitinib helped regrow hair in a teen with a unique pattern of alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Tofacitinib may help regrow hair in alopecia areata patients.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Björnstad syndrome can cause hair loss similar to androgenetic alopecia, and treatment with baricitinib and minoxidil may help.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

JAK inhibitors show promise for treating skin diseases effectively and safely.